- Home
- ASGN vs HAE Comparison
ASGN vs HAE Comparison
Compare ASGN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- HAE
- Stock Information
- Founded
- ASGN 1985
- HAE 1971
- Country
- ASGN United States
- HAE United States
- Employees
- ASGN N/A
- HAE N/A
- Industry
- ASGN Professional Services
- HAE Medical/Dental Instruments
- Sector
- ASGN Consumer Discretionary
- HAE Health Care
- Exchange
- ASGN Nasdaq
- HAE Nasdaq
- Market Cap
- ASGN 2.1B
- HAE 2.3B
- IPO Year
- ASGN 1992
- HAE 1991
- Fundamental
- Price
- ASGN $47.38
- HAE $49.13
- Analyst Decision
- ASGN Hold
- HAE Buy
- Analyst Count
- ASGN 6
- HAE 8
- Target Price
- ASGN $60.00
- HAE $76.88
- AVG Volume (30 Days)
- ASGN 606.7K
- HAE 981.6K
- Earning Date
- ASGN 10-22-2025
- HAE 11-06-2025
- Dividend Yield
- ASGN N/A
- HAE N/A
- EPS Growth
- ASGN N/A
- HAE 46.89
- EPS
- ASGN 3.15
- HAE 3.28
- Revenue
- ASGN $4,004,900,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- ASGN N/A
- HAE N/A
- Revenue Next Year
- ASGN $2.42
- HAE $6.42
- P/E Ratio
- ASGN $14.88
- HAE $15.29
- Revenue Growth
- ASGN N/A
- HAE 0.91
- 52 Week Low
- ASGN $45.10
- HAE $47.32
- 52 Week High
- ASGN $101.66
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- ASGN 44.11
- HAE 41.83
- Support Level
- ASGN $45.10
- HAE $48.17
- Resistance Level
- ASGN $49.30
- HAE $50.49
- Average True Range (ATR)
- ASGN 1.40
- HAE 1.53
- MACD
- ASGN -0.04
- HAE 0.47
- Stochastic Oscillator
- ASGN 54.05
- HAE 45.72
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.